Richard Rosenthal, MD, discusses allogenic cell therapy. The Food and Drug Administration (FDA) has not approved the injection of live cells in patients due to concerns about transmission or disease and uncontrolled cell growth. Instead, acellular methods such as injecting amniotic fluid or exosomes produced by mesenchymal stem cells can be used.
Published on April 04, 2022
Richard Rosenthal, MD, discusses allogenic cell therapy. The Food and Drug Administration (FDA) has not approved the injection of live cells in patients due to concerns about transmission or disease and uncontrolled cell growth. Instead, acellular methods such as injecting amniotic fluid or exosomes produced by mesenchymal stem cells can be used. These fluids come from donors and contain growth factors and matrix-building proteins that have regenerative effects.
Richard Rosenthal, MD, discusses allogenic cell therapy. The Food and Drug Administration (FDA) has not approved the injection of live cells in patients due to concerns about transmission or disease and uncontrolled cell growth. Instead, acellular methods such as injecting amniotic fluid or exosomes produced by mesenchymal stem cells can be used. These fluids come from donors and contain growth factors and matrix-building proteins that have regenerative effects.
You must be logged in to post a review.
Dr. Stogicza describes in great detail, the reemergence of prolotherapy, and why its efficacy is becoming more recognized in treating pain. She describes prolotherapy as “absolutely the opposite of every standard technique.” She explains how it is categorized as regenerative therapy, and gives an example of how prolotherapy is used to treat the root cause of cervicogenic headaches by allowing the body to heal the ligamentous (soft tissue) damage that can refer pain to cause such headaches.
Renowned pain expert Dr. Richard Rauck discusses how pain education is changing. He emphasizes the importance of physician training in multiple areas, including neuroradiology and psychiatry, then considers the role of device innovation and drug development in pain management. Dr. Rauck finishes with a discussion of the opioid crisis and the role of physicians in reducing the burden of opioid use in pain management.
Dr. Kenneth Candido reviews the ever growing and complex world of reimbursement for chronic pain. A question example: When should ultrasounds be used? This question can be thought of from many angles including safety, efficacy, and reimbursement. Dr. Candido provide a practical framework for trainees in order to provide the best treatment possible for their patients.
Dr. Ramsin Benyamin gives a brief talk on osteoporotic fractures and how he has focused his practice in preventing these atraumatic fractures. He explains how the consequences of such fractures can be life altering. He also discusses bone density preservation and the proper treatment for such fractures, including vertebroplasty and kyphoplasty.
Reviews
There are no reviews yet.